Co-Authors
This is a "connection" page, showing publications co-authored by Farzaneh Dastan and Nassim Anjidani.
Connection Strength
0.115
-
Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis. Expert Rev Clin Immunol. 2021 05; 17(5):499-511.
Score: 0.059
-
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. Int Immunopharmacol. 2020 Dec; 89(Pt B):107102.
Score: 0.057